Seasonal Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Seasonal Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-29Clinical Trial Update: An Exploratory Study of PQ Grass 27600 SU [Phase 2, Phase 3]
An exploratory study of PQ Grass 27600 SU completed phases 2 and 3 for seasonal allergic rhinitis, with results posted in 2026.
-
CLINICAL_TRIALS trial_result · 2026-04-29Clinical Trial Results: An Exploratory Study of PQ Grass 27600 SU [Phase 2, Phase 3]
Results from an exploratory phase 2/3 trial of PQ Grass 27600 SU in seasonal allergic rhinitis have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Special Drug Use Observational Study of Xolair in Patients With Severe to Most Severe Seasonal Allergic Rhinitis Aged ≥ 12 Years and < 18 Years Whose Symptoms Were Inadequately Controlled Despite to Conventional Therapies
This clinical trial update reports a special drug use observational study of omalizumab (Xolair) in adolescents aged 12 to 17 with seasonal …
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Clinical Trial of TQC2938 Injection in Patients With Seasonal Allergic Rhinitis [Phase 2]
Phase 2 clinical trial of TQC2938 injection for seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Efficacy and Safety of LP-003 Injection in Patients With Moderate to Severe Seasonal Allergic Rhinitis [Phase 3]
Phase 3 clinical trial update evaluating the efficacy and safety of LP-003 injection in patients with moderate to severe seasonal allergic r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: Efficacy and Safety of LP-003 in Moderate-to-severe Seasonal Allergic Rhinitis Adult [Phase 2]
Phase 2 trial update assessing the efficacy and safety of LP-003 in adults with moderate-to-severe seasonal allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients [Phase 1]
Phase 1 clinical pharmacology study of MT-2990 in seasonal allergic rhinitis has been completed, providing early pharmacokinetic and safety …
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Phleum Pratense and Dactylis Glomerata Allergen Extracts Standardization [NA]
A completed clinical trial from Inmunotek S.L. focusing on standardizing Phleum pratense and Dactylis glomerata allergen extracts for pollen…
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis [Phase 2]
This document describes a Phase 2 clinical trial evaluating the efficacy, safety, pharmacokinetics and pharmacodynamics of SHR-1819 injectio…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis [Phase 2]
Phase 2 clinical trial of TQH2722 Injection for seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: A Motivation-enhancing App to Retain Patients With Hay Fever in a Trial After Treatment [NA]
This clinical trial update reports a completed study investigating a motivation-enhancing app aimed at retaining hay fever patients during a…
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: Phase II Study of JT002 in the Treatment of Seasonal Allergic Rhinitis in Adults [Phase 2]
Phase II clinical trial of JT002 for Seasonal Allergic Rhinitis in adults has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Immunological Analysis of Lymph Node Tissue After Intralymphatic Immunotherapy: A Prospective Case Control Study [EARLY_Phase 1]
An early Phase 1 trial from the University of Zurich evaluated immunological changes in lymph node tissue after intralymphatic immunotherapy…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract [Phase 1, Phase 2]
This entry reports the completion of a Phase 1/2 clinical trial evaluating intralymphatic immunotherapy with Polvac grass and rye allergen e…
-
CLINICAL_TRIALS trial_result · 2025-04-25Clinical Trial Update: A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR). [Phase 2]
Phase 2 study evaluating an IL4Rα monoclonal antibody for seasonal allergic rhinitis; the trial is currently listed as active but not recrui…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen [Phase 3]
Phase 3 trial evaluating PQ Grass for grass pollen–induced seasonal allergic rhinitis and rhinoconjunctivitis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Threshold Concentrations for Ragweed and Birch Pollen in Seasonal Allergic Rhinitis [NA]
A clinical trial evaluating threshold pollen concentrations for ragweed and birch pollen in seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: Factors Involved in Dymista's Superior Clinical Efficacy in the Treatment of Seasonal Allergic Rhinitis [Phase 4]
A Phase 4 clinical trial update reports superior efficacy of Dymista (azelastine hydrochloride and fluticasone propionate nasal spray) in tr…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: An Approved Drug to Study a New Indication for Allergic Rhinitis (0476-327) [Phase 3]
Phase 3 trial update on an approved drug being studied for a new indication in seasonal allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269) [Phase 3]
This update reports the completion of a Phase 3 trial investigating a new indication for an approved drug to treat seasonal allergic rhiniti…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR) (Study P04054) [Phase 4]
Phase 4 randomized trial comparing desloratadine, fexofenadine 180 mg, and placebo for seasonal allergic rhinitis. The study assessed effica…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR)(Study P04053)(COMPLETED) [Phase 4]
A Phase 4 randomized trial comparing desloratadine, fexofenadine 180 mg, and placebo for seasonal allergic rhinitis, assessing efficacy and …
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Effects of Loratadine/Montelukast vs Pseudoephedrine and Placebo in Patients With Seasonal Allergic Rhinitis (Study P04095) (COMPLETED) [Phase 3]
Phase 3 trial evaluating loratadine/montelukast versus pseudoephedrine and placebo for seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Effect of Loratadine/Montelukast Combination on Congestion in SAR Patients Exposed to Pollen in an EEU (Study P04822) [Phase 3]
Phase 3 trial evaluating the loratadine/montelukast combination for congestion in Seasonal Allergic Rhinitis patients exposed to pollen; the…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Comparison of the Effects of Desloratadine and Placebo in the Relief of Nasal Symptom Scores in Subjects With Seasonal Allergic Rhinitis to Cypress Pollen (Study P02836) [Phase 4]
A Phase 4 randomized trial comparing desloratadine to placebo for relief of nasal symptoms in seasonal allergic rhinitis due to Cypress poll…